Injective (INJ) traded at $7.07 on Binance, below the critical $7.33 neckline linked to a potential $13.40 cup-and-handle price target. The bullish scenario hinges on INJ recovering above the $7.21-$7.35 resistance zone and holding the $7.33 level, which would signal momentum improvement. Support levels to watch are $6.88 and $6.70, with a break below $6.70 shifting focus to the 50-day moving average near $6.44. Market indicators are mixed, and futures data shows a slight decline in open interest, reflecting cautious trader sentiment. The $13.40 target remains conditional and not guaranteed without a confirmed breakout above resistance.
Injective (INJ) is trading at Rp130.036 on Pluang as of Oct 10, 2026 18:01 WIB, showing a 3.61% gain over the past day. Despite the article noting a price below the $7.33 neckline, Pluang data indicates a positive daily change. Market activity on Pluang shows a slight sell bias with 53% of orders to sell and a typical holding period of 38 days, suggesting cautious but engaged investor interest.
Injective's native token INJ fell 2.05% to $7.18 over 24 hours while futures open interest surged 21.49%, indicating increased derivatives exposure during the price decline. Technical indicators showed mixed signals, with INJ trading below some movin...
Analyst Ali Martinez highlights three altcoins—XRP, Quant (QNT), and Injective (INJ)—each at crucial technical points signaling potential breakouts. XRP has broken above a descending resistance line, with $1.50 as a key support level and $1.62 as the...
The Injective Foundation has launched the Trench Treasury to reward projects and community members who actively grow its ecosystem. The first INJ token rewards were given to Sprout and RunUp, two projects credited with onboarding users and developers...
Canary Capital has filed with the SEC to launch a staked INJ ETF, aiming to provide institutional exposure to Injective while earning additional INJ through staking. The ETF is expected to launch before 2027, pending SEC approval. Meanwhile, the Inje...
